386 related articles for article (PubMed ID: 11163474)
1. Passive immunization for the prevention of otitis media.
Englund JA; Glezen WP
Vaccine; 2000 Dec; 19 Suppl 1():S116-21. PubMed ID: 11163474
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of bacterial polysaccharide immune globulin for the treatment or prevention of Haemophilus influenzae type b and pneumococcal disease.
Siber GR; Thompson C; Reid GR; Almeido-Hill J; Zacher B; Wolff M; Santosham M
J Infect Dis; 1992 Jun; 165 Suppl 1():S129-33. PubMed ID: 1588146
[TBL] [Abstract][Full Text] [Related]
3. Predominance of nontypeable Haemophilus influenzae in children with otitis media following introduction of a 3+0 pneumococcal conjugate vaccine schedule.
Wiertsema SP; Kirkham LA; Corscadden KJ; Mowe EN; Bowman JM; Jacoby P; Francis R; Vijayasekaran S; Coates HL; Riley TV; Richmond P
Vaccine; 2011 Jul; 29(32):5163-70. PubMed ID: 21621576
[TBL] [Abstract][Full Text] [Related]
4. Acute otitis media in the era of effective pneumococcal conjugate vaccine: will new pathogens emerge?
Pelton SI
Vaccine; 2000 Dec; 19 Suppl 1():S96-9. PubMed ID: 11163471
[TBL] [Abstract][Full Text] [Related]
5. Mucosal vaccination against encapsulated respiratory bacteria--new potentials for conjugate vaccines?
Jakobsen H; Jonsdottir I
Scand J Immunol; 2003 Aug; 58(2):119-28. PubMed ID: 12869132
[TBL] [Abstract][Full Text] [Related]
6. Mother-infant vaccination with pneumococcal polysaccharide vaccine: persistence of maternal antibodies and responses of infants to vaccination.
Holmlund E; Nohynek H; Quiambao B; Ollgren J; Käyhty H
Vaccine; 2011 Jun; 29(28):4565-75. PubMed ID: 21550374
[TBL] [Abstract][Full Text] [Related]
7. The potential for using protein vaccines to protect against otitis media caused by Streptococcus pneumoniae.
Briles DE; Hollingshead SK; Nabors GS; Paton JC; Brooks-Walter A
Vaccine; 2000 Dec; 19 Suppl 1():S87-95. PubMed ID: 11163470
[TBL] [Abstract][Full Text] [Related]
8. Pneumococcal otitis media and pneumococcal vaccines, a historical perspective.
Austrian R
Vaccine; 2000 Dec; 19 Suppl 1():S71-7. PubMed ID: 11163467
[TBL] [Abstract][Full Text] [Related]
9. Vaccination against middle-ear bacterial and viral pathogens.
Giebink GS
Ann N Y Acad Sci; 1997 Dec; 830():330-52. PubMed ID: 9616694
[TBL] [Abstract][Full Text] [Related]
10. Polysaccharide-based pneumococcal vaccines in the prevention of acute otitis media.
Eskola J
Vaccine; 2000 Dec; 19 Suppl 1():S78-82. PubMed ID: 11163468
[TBL] [Abstract][Full Text] [Related]
11. Impact of protein D-containing pneumococcal conjugate vaccines on non-typeable Haemophilus influenzae acute otitis media and carriage.
Clarke C; Bakaletz LO; Ruiz-Guiñazú J; Borys D; Mrkvan T
Expert Rev Vaccines; 2017 Jul; 16(7):1-14. PubMed ID: 28571504
[TBL] [Abstract][Full Text] [Related]
12. Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study.
Prymula R; Peeters P; Chrobok V; Kriz P; Novakova E; Kaliskova E; Kohl I; Lommel P; Poolman J; Prieels JP; Schuerman L
Lancet; 2006 Mar; 367(9512):740-8. PubMed ID: 16517274
[TBL] [Abstract][Full Text] [Related]
13. Effect of vaccination with pneumococcal capsular polysaccharides conjugated to Haemophilus influenzae-derived protein D on nasopharyngeal carriage of Streptococcus pneumoniae and H. influenzae in children under 2 years of age.
Prymula R; Kriz P; Kaliskova E; Pascal T; Poolman J; Schuerman L
Vaccine; 2009 Dec; 28(1):71-8. PubMed ID: 19818722
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity and safety of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccine (PHiD-CV) co-administered with routine childhood vaccines in Taiwan.
Lin TY; Lu CY; Chang LY; Chiu CH; Huang YC; Bock HL; Tang H; François N; Moreira M; Schuerman L; Huang LM
J Formos Med Assoc; 2012 Sep; 111(9):495-503. PubMed ID: 23021506
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of pneumococcal vaccination against recurrent otitis media. Preliminary results of a field trial in Finland.
Karma P; Luotonen J; Timonen M; Pöntynen S; Pukander J; Herva E; Grönroos P; Leinonen M; Sibakov M; Mäkelä PH
Ann Otol Rhinol Laryngol Suppl; 1980; 89(3 Pt 2):357-62. PubMed ID: 6778346
[TBL] [Abstract][Full Text] [Related]
16. Pneumococcal conjugate vaccine primes for polysaccharide-inducible IgG2 antibody response in children with recurrent otitis media acuta.
Breukels MA; Rijkers GT; Voorhorst-Ogink MM; Zegers BJ; Sanders LA
J Infect Dis; 1999 May; 179(5):1152-6. PubMed ID: 10191217
[TBL] [Abstract][Full Text] [Related]
17. [Hemophilus influenzae infection and their prevention by vaccination].
Scholz H; Noack R
Kinderarztl Prax; 1993 Aug; 61(6):189-91. PubMed ID: 8411843
[TBL] [Abstract][Full Text] [Related]
18. Maternal immunization with pneumococcal 9-valent conjugate vaccine and early infant otitis media.
Daly KA; Scott Giebink G; Lindgren BR; Knox J; Haggerty BJ; Nordin J; Goetz S; Ferrieri P
Vaccine; 2014 Dec; 32(51):6948-6955. PubMed ID: 25444821
[TBL] [Abstract][Full Text] [Related]
19. Pneumococcal conjugate vaccine for young children.
Selman S; Hayes D; Perin LA; Hayes WS
Manag Care; 2000 Sep; 9(9):49-52, 54, 56-7 passim. PubMed ID: 11116663
[TBL] [Abstract][Full Text] [Related]
20. Vaccines for Nontypeable Haemophilus influenzae: the Future Is Now.
Murphy TF
Clin Vaccine Immunol; 2015 May; 22(5):459-66. PubMed ID: 25787137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
